Skip to main content
OpenTrials
Completed

NCT Number: NCT05397444

Handgrip Strength (HGS) With HGS Asymmetry Are Associated With All-cause Mortality and Hospital Readmissions

Adding the handgrip strength (HGS) asymmetry to the existing measurements of low HGS may improve the assessment of muscle function.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Nanjing medical university

Nanjing, China

About this study

We sought to explore the associations between maximal HGS with HGS asymmetry and mortality, hospital readmissions, total complications, and prolonged length of stay (PLOS) among elderly patients with gastric cancer.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • with gastric cancer
  • aged ≥60 years
  • were scheduled to undergo radical surgery for the first time

Exclusion criteria

  • received preoperative radiotherapy or chemotherapy
  • combined with other types of malignant tumors

Treatment and study plan

No intervention

Other

This is an observational study with no intervention.

Primary outcomes

  1. All-cause mortality

    Time frame: about 3 months

    within 3 months after surgery, collected from telephone follow-up

  2. Hospital readmissions

    Time frame: about 3 months

    wihthin 3 months after surgery, collected from telephone follow-up

Secondary outcomes

  1. Total complications

    Time frame: about 3 months

    during hospitalization, collected from medical records

  2. prolonged length of stay

    Time frame: about 3 months

    during hospitalization, collected from medical records

Sponsors and collaborators

Lead sponsor

Nanjing Medical University

Other

Registry information

Official study title

Handgrip Strength (HGS) With HGS Asymmetry is Associated With All-cause Mortality and Hospital Readmissions Among Elderly Patients With Gastric Cancer.

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
May 31, 2022
Registry last updated
May 31, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.